activPAL Device for Stroke

(RIsE Trial)

This trial aims to understand how patients with severe strokes move during their hospital stay. Researchers will use a small wearable device called activPAL to track movements and compare them with usual care mobility data. The goal is to learn about typical movement patterns after a stroke and assess how well patients meet their mobility goals. This information could help improve long-term mobility treatments for stroke patients. The trial is suitable for adults hospitalized with a severe ischemic stroke who can move with assistance and do not have severe mobility limitations from other conditions. As an unphased trial, it offers patients the opportunity to contribute to research that could enhance future mobility treatments for stroke survivors.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that the activPAL device is generally easy to use and comfortable. This small, wearable gadget tracks movement and has undergone testing in several studies. These studies evaluated its effectiveness and ease of use for patients after a stroke.

Regarding safety, no major issues have emerged. The device has been used with various groups, including older adults, and has proven reliable in measuring activities like sitting, standing, and walking. Reports of serious side effects or discomfort from wearing it have not surfaced.

Researchers are excited about the use of the activPAL device for stroke patients because it offers a unique way to monitor and understand mobility patterns. Unlike traditional treatments for ischemic stroke, which often focus on medication and physical therapy, the activPAL device provides real-time data on how patients move during recovery. This can help tailor rehabilitation programs more precisely to each patient's needs, potentially improving outcomes. The device's ability to offer continuous, detailed tracking sets it apart from standard care options, offering new insights into patient mobility that could enhance recovery strategies.

Research has shown that the activPAL device effectively tracks movement, particularly in individuals who have experienced a severe stroke. In this trial, researchers will observe hospitalized adult patients with severe acute ischemic stroke using the activPAL4pro device to monitor mobility patterns during hospitalization. This small, wearable gadget records data on the quantity and quality of patient movement, including posture and limb movements. This information aids in understanding normal movement patterns and their changes during hospital stays. Analyzing this data allows healthcare providers to enhance treatment plans, ultimately improving stroke patients' mobility over time. While the device does not treat the stroke itself, it provides valuable insights that could lead to better recovery strategies.¹³⁴⁶⁷